Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Erviti

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Radiology|September 22, 2007
Fracture risk scoreJavier Gorricho, Juan Erviti
JAMA|May 10, 2007
Use of alendronate after 5 years of treatmentJuan Erviti, Javier Gorricho
ESC Heart Failure|August 18, 2019
Medical journals and editorial quality controlJuan Erviti, Luis Carlos Saiz, Leire Leache
BMJ Evidence-Based Medicine|April 14, 2018
When authors lie, readers cry and editors sighLuis Carlos Saiz, Juan Erviti, Javier Garjón
BMJ Evidence-Based Medicine|December 13, 2025
Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisionsJuan Erviti, Luis Carlos Saiz, Marta Gutiérrez-Valencia
BMJ Open|February 23, 2013
Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control studyJuan Erviti, Alvaro Alonso, Javier Gorricho, et al.
Plos Neglected Tropical Diseases|July 7, 2025
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosisMarta Gutiérrez-Valencia, Luis Carlos Saiz, Juan Erviti
BMJ (Clinical Research Ed.)|February 25, 2026
Adherence to legislation and recommendations to publicly post protocols and results of post-authorisation studies registered with European Medicines Agency: cross sectional studyPedram Ramezani, Juan Erviti, Peter Doshi, et al.
Medicina Clinica|November 10, 2016
The reliability of clinical trials. The risky way towards drug deregulationJuan Erviti López, Luis Carlos Saiz Fernández, Javier Garjón Parra
Gaceta Sanitaria|July 30, 2020
[Orphan drugs, incentives and uncertainty about their risk-benefit balance]Leire Leache, Luis Carlos Saiz, Marta Gutiérrez-Valencia, et al.
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Radiology|September 22, 2007
Fracture risk scoreJavier Gorricho, Juan Erviti
JAMA|May 10, 2007
Use of alendronate after 5 years of treatmentJuan Erviti, Javier Gorricho
ESC Heart Failure|August 18, 2019
Medical journals and editorial quality controlJuan Erviti, Luis Carlos Saiz, Leire Leache
BMJ Evidence-Based Medicine|April 14, 2018
When authors lie, readers cry and editors sighLuis Carlos Saiz, Juan Erviti, Javier Garjón
BMJ Evidence-Based Medicine|December 13, 2025
Ataluren for Duchenne: how politics and social pressure undermined evidence-based decisionsJuan Erviti, Luis Carlos Saiz, Marta Gutiérrez-Valencia
BMJ Open|February 23, 2013
Oral bisphosphonates may not decrease hip fracture risk in elderly Spanish women: a nested case-control studyJuan Erviti, Alvaro Alonso, Javier Gorricho, et al.
Plos Neglected Tropical Diseases|July 7, 2025
Potential bias in the analysis of prenatal treatment for congenital toxoplasmosisMarta Gutiérrez-Valencia, Luis Carlos Saiz, Juan Erviti
BMJ (Clinical Research Ed.)|February 25, 2026
Adherence to legislation and recommendations to publicly post protocols and results of post-authorisation studies registered with European Medicines Agency: cross sectional studyPedram Ramezani, Juan Erviti, Peter Doshi, et al.
Medicina Clinica|November 10, 2016
The reliability of clinical trials. The risky way towards drug deregulationJuan Erviti López, Luis Carlos Saiz Fernández, Javier Garjón Parra
Gaceta Sanitaria|July 30, 2020
[Orphan drugs, incentives and uncertainty about their risk-benefit balance]Leire Leache, Luis Carlos Saiz, Marta Gutiérrez-Valencia, et al.
Pageof 5